Cargando…

Serum interleukin 1β in patients with acquired laryngotracheal stenosis

OBJECTIVES: To determine the serum levels of interleukin-1beta (IL-1β) in patients with acquired laryngotracheal stenosis (ALTS) and healthy volunteers and compare levels between serum and tissue of the stenotic segment. MATERIALS AND METHODS: An exploratory cohort study included 20 participants wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Azwal, Norazwani, Lokanathan, Yogeswaran, Azman, Mawaddah, Ng, Min Hwei, Mohamed, Abdullah Sani, Baki, Marina Mat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Pacini Editore Srl 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9330755/
https://www.ncbi.nlm.nih.gov/pubmed/35880366
http://dx.doi.org/10.14639/0392-100X-N1981
_version_ 1784758239259262976
author Azwal, Norazwani
Lokanathan, Yogeswaran
Azman, Mawaddah
Ng, Min Hwei
Mohamed, Abdullah Sani
Baki, Marina Mat
author_facet Azwal, Norazwani
Lokanathan, Yogeswaran
Azman, Mawaddah
Ng, Min Hwei
Mohamed, Abdullah Sani
Baki, Marina Mat
author_sort Azwal, Norazwani
collection PubMed
description OBJECTIVES: To determine the serum levels of interleukin-1beta (IL-1β) in patients with acquired laryngotracheal stenosis (ALTS) and healthy volunteers and compare levels between serum and tissue of the stenotic segment. MATERIALS AND METHODS: An exploratory cohort study included 20 participants with ALTS and 5 healthy volunteers. ALTS group was categorised into mild and severe according to grade of stenosis and presence of tracheostomy. Comparisons of serum levels of IL-1β between pre- and post-surgical intervention and between blood and tissue samples in the severe ALTS group were made. Correlation of IL-1β levels between blood and tissue was assessed using Spearman’s correlation. RESULTS: Severe ALTS patients showed higher serum levels of IL-1β compared to mild ALTS and healthy volunteers (p = 0.045). IL-1β was higher before surgical intervention than after surgical intervention (p = 0.003). There was a strong positive correlation of IL-1β between serum and tissue (r = 0.74, p = 0.035). CONCLUSION: Serum levels of IL-1β are higher in ALTS patients than in healthy controls and positively correlate with tissue levels. The decreasing trend of serum IL-1β observed following successful surgical intervention reflects the absence of ongoing inflammation at the stenotic segment.
format Online
Article
Text
id pubmed-9330755
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Pacini Editore Srl
record_format MEDLINE/PubMed
spelling pubmed-93307552022-08-09 Serum interleukin 1β in patients with acquired laryngotracheal stenosis Azwal, Norazwani Lokanathan, Yogeswaran Azman, Mawaddah Ng, Min Hwei Mohamed, Abdullah Sani Baki, Marina Mat Acta Otorhinolaryngol Ital Laryngology OBJECTIVES: To determine the serum levels of interleukin-1beta (IL-1β) in patients with acquired laryngotracheal stenosis (ALTS) and healthy volunteers and compare levels between serum and tissue of the stenotic segment. MATERIALS AND METHODS: An exploratory cohort study included 20 participants with ALTS and 5 healthy volunteers. ALTS group was categorised into mild and severe according to grade of stenosis and presence of tracheostomy. Comparisons of serum levels of IL-1β between pre- and post-surgical intervention and between blood and tissue samples in the severe ALTS group were made. Correlation of IL-1β levels between blood and tissue was assessed using Spearman’s correlation. RESULTS: Severe ALTS patients showed higher serum levels of IL-1β compared to mild ALTS and healthy volunteers (p = 0.045). IL-1β was higher before surgical intervention than after surgical intervention (p = 0.003). There was a strong positive correlation of IL-1β between serum and tissue (r = 0.74, p = 0.035). CONCLUSION: Serum levels of IL-1β are higher in ALTS patients than in healthy controls and positively correlate with tissue levels. The decreasing trend of serum IL-1β observed following successful surgical intervention reflects the absence of ongoing inflammation at the stenotic segment. Pacini Editore Srl 2022-06-30 2022-06 /pmc/articles/PMC9330755/ /pubmed/35880366 http://dx.doi.org/10.14639/0392-100X-N1981 Text en Società Italiana di Otorinolaringoiatria e Chirurgia Cervico-Facciale, Rome, Italy https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed in accordance with the CC-BY-NC-ND (Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International) license. The article can be used by giving appropriate credit and mentioning the license, but only for non-commercial purposes and only in the original version. For further information: https://creativecommons.org/licenses/by-nc-nd/4.0/deed.en
spellingShingle Laryngology
Azwal, Norazwani
Lokanathan, Yogeswaran
Azman, Mawaddah
Ng, Min Hwei
Mohamed, Abdullah Sani
Baki, Marina Mat
Serum interleukin 1β in patients with acquired laryngotracheal stenosis
title Serum interleukin 1β in patients with acquired laryngotracheal stenosis
title_full Serum interleukin 1β in patients with acquired laryngotracheal stenosis
title_fullStr Serum interleukin 1β in patients with acquired laryngotracheal stenosis
title_full_unstemmed Serum interleukin 1β in patients with acquired laryngotracheal stenosis
title_short Serum interleukin 1β in patients with acquired laryngotracheal stenosis
title_sort serum interleukin 1β in patients with acquired laryngotracheal stenosis
topic Laryngology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9330755/
https://www.ncbi.nlm.nih.gov/pubmed/35880366
http://dx.doi.org/10.14639/0392-100X-N1981
work_keys_str_mv AT azwalnorazwani seruminterleukin1binpatientswithacquiredlaryngotrachealstenosis
AT lokanathanyogeswaran seruminterleukin1binpatientswithacquiredlaryngotrachealstenosis
AT azmanmawaddah seruminterleukin1binpatientswithacquiredlaryngotrachealstenosis
AT ngminhwei seruminterleukin1binpatientswithacquiredlaryngotrachealstenosis
AT mohamedabdullahsani seruminterleukin1binpatientswithacquiredlaryngotrachealstenosis
AT bakimarinamat seruminterleukin1binpatientswithacquiredlaryngotrachealstenosis